PRINCETON, N.J., June 16, 2020 /PRNewswire/ — Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced
Princeton, NJ – May 27, 2020 – Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device
Prediction: In 10 years, clinical trials will be nearly paperless. And clinical trial historians will note that the Coronavirus pandemic
With increasing drug development costs and complexity, meaningful clinical partnerships can help sponsors establish their most efficient and cost-effective processes.
WEBINAR Customize Your Clinical Metadata Repositories and Statistical Computing Environments Watch our webinar to learn how to manage the growing
The start of the new year brought some changes for the FDA and EMA. In an effort to keep you
March 18, 2020 Hello Everyone, This is to inform you that Quartesian is closely tracking the Coronavirus (COVID-19) pandemic outbreak
Throughout 2019, Quartesian continues to gain momentum with strong uptake rates for new services and large contract growth. With over
Quartesian is excited to announce a new offering: a suite of clinical trial data pharmacovigilance services. Our services for clinical
Quartesian has entered a multi-year agreement with Medrio, a leading eClinical technology provider, to provide even more high-quality data to
CRO Gives Sponsors the Best of Both Worlds By Partnering with Quartesian The Challenge: Offer Midsize CRO Benefits With Large
Quartesian, a leading data CRO quickly becoming a clinical data services industry favorite, recently announced a second consecutive year of
